{
  "url": "https://www.morningstar.com/news/globe-newswire/9521700/rxsight-inc-nasdaq-rxst-shareholder-alert-bernstein-liebhard-llp-reminds-rxsight-inc-investors-of-upcoming-deadline",
  "authorsByline": "",
  "articleId": "9737ece6fd174d0c9816e3d11f187eac",
  "source": {
    "domain": "morningstar.com",
    "location": {
      "country": "us",
      "state": "IL",
      "county": "Cook County",
      "city": "Chicago",
      "coordinates": {
        "lat": 41.8755616,
        "lon": -87.6244212
      }
    }
  },
  "imageUrl": "https://images.contentstack.io/v3/assets/blt4eb669caa7dc65b2/blta7dd42ebdd7b93b8/61899b34a3c7df383578294c/morningstar-og.png",
  "country": "us",
  "language": "en",
  "pubDate": "2025-09-02T08:36:13-05:00",
  "addDate": "2025-09-02T14:01:50.601893+00:00",
  "refreshDate": "2025-09-02T14:01:50.601897+00:00",
  "score": 1.0,
  "title": "RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline",
  "description": "RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline  Morningstar",
  "content": "NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (\u201cRxSight\u201d or the \u201cCompany\u201d) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.\n\nShould You Join This Class Action Lawsuit?\n\u2022 Do you, or did you, own shares of RxSight, Inc. (NASDAQ: RXST)?\n\u2022 Did you purchase your shares between November 7, 2024 and July 8, 2025, inclusive?\n\u2022 Did you lose money in your investment in RxSight, Inc.?\n\n\n\nIf you purchased or acquired RxSight securities, and/or would like to discuss your legal rights and options please visit RxSight, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.\n\nA lawsuit was filed in the United States District Court for the Central District of California on behalf of investors who purchased or acquired the securities of RxSight between November 7, 2024 and July 8, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.\n\nAccording to the lawsuit, Defendants, among other things, overstated the demand for RxSight\u2019s products and failed to disclose that the Company was experiencing \u201cadoption challenges\u201d and structural issues resulting in declines in sales.\n\nIf you wish to serve as lead plaintiff for the Class, you must file papers by September 22, 2025. A lead plaintiff is a representative party acting on other class members\u2019 behalf in directing the litigation. Your ability to share in any recovery doesn\u2019t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.\n\nAll representation is on a contingency fee basis. Shareholders pay no fees or expenses.\n\nSince 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal\u2019s \u201cPlaintiffs\u2019 Hot List\u201d thirteen times and listed in The Legal 500 for sixteen consecutive years.\n\nATTORNEY ADVERTISING. \u00a9 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.",
  "medium": "Article",
  "links": [
    "https://www.globenewswire.com/Tracker?data=Uldqt2_M61pPMDojlnvTHArtaE7T9ZerJaGrq5VopA_ULRVHum4Xwno22Pk8GHgQXPX4ruaS2QbR6p5Yeql3ZBxG_zuyPa65fSFqJFjZkQGVLn69MkuzeWMY_WrKcwLCriwS6x-50ULUmtLSw4YsxPJaTmcFW-G1VDkdCwbN9kKCu_Vrif0JhEyNwd1SfK1xJAEMP9iQp43S5dHrwUJMG9l3Dz2MDvckgH4Ei1PfvEI=",
    "https://www.globenewswire.com/Tracker?data=3x4ov1VbrGuroCH8fGe8J4O3FDgr4ZuFvvDgX45N5eaMYz4OiIpkhfOrXYAW4mho4-Hj716CAOuDZ0WWfZyUbSVrYXGbCzMMtWMYeNrPinc=",
    "https://www.globenewswire.com/Tracker?data=BAwvMi83kDLokLKaN84CbwwtMGTkI0X-HWmPEv9xFPcXeYwSfnIorWH3rqn61oWxAgNUM3KyvJFBHsJexn3U_aBiqRbKb_KR6d602YF-6jE=",
    "https://www.globenewswire.com/NewsRoom/AttachmentNg/5d514042-8326-4555-8ad7-f6cc765ecfcd",
    "https://www.globenewswire.com/Tracker?data=F0EddHzSfwX_l45XuRl7nW2MqSEOVz9_Wop8f-47e-ZYyDKIseOuldjRZiygAVNpkvmai_NdiiVrF_rUUvxr5dAhulP4cGsnYtzh00I7IFo=",
    "https://www.globenewswire.com/Tracker?data=3x4ov1VbrGuroCH8fGe8J4O3FDgr4ZuFvvDgX45N5eavUlFsIv7fij6Bx-_qyfyr8H517JwPkPXz0T-wXs_fKR7yslkaCD_blyKuTdNf_48="
  ],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "RxSight Inc. Investors",
      "weight": 0.11093935
    },
    {
      "name": "Shareholder Class Action Lawsuit",
      "weight": 0.101710156
    },
    {
      "name": "RxSight Inc.",
      "weight": 0.09666128
    },
    {
      "name": "class actions",
      "weight": 0.095421016
    },
    {
      "name": "RxSight securities",
      "weight": 0.093212225
    },
    {
      "name": "Bernstein Liebhard LLP",
      "weight": 0.08791425
    },
    {
      "name": "RxSight",
      "weight": 0.08359891
    },
    {
      "name": "SHAREHOLDER ALERT Bernstein Liebhard LLP",
      "weight": 0.08102296
    },
    {
      "name": "individual investors",
      "weight": 0.07915927
    },
    {
      "name": "investors",
      "weight": 0.07680316
    }
  ],
  "topics": [
    {
      "name": "Stocks"
    },
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Company News",
      "score": 0.9873046875
    },
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.97900390625
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.9697265625
    },
    {
      "name": "/Law & Government/Legal/Other",
      "score": 0.78662109375
    },
    {
      "name": "/Law & Government/Legal/Business & Corporate Law",
      "score": 0.72998046875
    },
    {
      "name": "/Law & Government/Legal/Legal Services",
      "score": 0.6669921875
    },
    {
      "name": "/Finance/Investing/Other",
      "score": 0.642578125
    },
    {
      "name": "/Law & Government/Public Safety/Crime & Justice",
      "score": 0.308349609375
    }
  ],
  "sentiment": {
    "positive": 0.10147433,
    "negative": 0.3213844,
    "neutral": 0.5771413
  },
  "summary": "Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, has issued a deadline for investors in RxSight, Inc. (NASDAQ: RXST) to register in a securities fraud class action lawsuit against the company. The lawsuit alleges violations of the Securities Exchange Act of 1934 against the Company and its senior officers. If you own shares of RxScient, or acquired during the period of November 7, 2024 and July 8, 2025, you must register by September 22, 2025. Since 1993, Bernstein Liebhardt LLP has recovered over $3.5 billion for its clients and has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf.",
  "shortSummary": "Bernstein Liebhard LLP reminds RxSight Inc. investors of an upcoming securities fraud class action lawsuit, alleging violations of the Securities Exchange Act, requiring filing by September 22.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "d557d24e9a324f2185f2afc4763dd779",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://www.globenewswire.com/Tracker?data=Uldqt2_M61pPMDojlnvTHArtaE7T9ZerJaGrq5VopA_ULRVHum4Xwno22Pk8GHgQXPX4ruaS2QbR6p5Yeql3ZBxG_zuyPa65fSFqJFjZkQGVLn69MkuzeWMY_WrKcwLCriwS6x-50ULUmtLSw4YsxPJaTmcFW-G1VDkdCwbN9kKCu_Vrif0JhEyNwd1SfK1xJAEMP9iQp43S5dHrwUJMG9l3Dz2MDvckgH4Ei1PfvEI=",
      "text": "RXSIGHT, INC. SHAREHOLDERS HAVE AN OPPORTUNITY TO RECOVER THEIR INVESTMENT LOSSES\nRxSight, Inc.\nBernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired RxSight, Inc. (\u201cRxSight\u201d or the \u201cCompany\u201d) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive. The lawsuit seeks to recover RxSight shareholders\u2019 investment losses.\nIf you purchased securities in RxSight between November 7, 2024 and July 8, 2025, inclusive, and would like to discuss your legal rights and/or options, please click \u201cJoin Class Action\u201d above.\nAccording to the lawsuit, Defendants, among other things, overstated the demand for RxSight\u2019s products and failed to disclose that the Company was experiencing \u201cadoption challenges\u201d and structural issues resulting in declines in sales.\nIf you wish to serve as lead plaintiff for the Class, you must file papers by September 22, 2025. A lead plaintiff is a representative party acting on other class members\u2019 behalf in directing the litigation. Your ability to share in any recovery doesn\u2019t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.\nAll representation is on a contingency fee basis. Shareholders pay no fees or expenses.\nSince 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal\u2019s \u201cPlaintiffs\u2019 Hot List\u201d thirteen times and listed in The Legal 500 for sixteen consecutive years.\nATTORNEY ADVERTISING. \u00a9 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.\nContact Information:\nPeter Allocco\nInvestor Relations Manager\nBernstein Liebhard LLP\nhttps://www.bernlieb.com\n(212) 951-2030\npallocco@bernlieb.com"
    },
    {
      "url": "https://www.globenewswire.com/Tracker?data=F0EddHzSfwX_l45XuRl7nW2MqSEOVz9_Wop8f-47e-ZYyDKIseOuldjRZiygAVNpkvmai_NdiiVrF_rUUvxr5dAhulP4cGsnYtzh00I7IFo=",
      "text": "Bernstein Liebhard LLP is a nationally-recognized securities litigation firm, advising individual and institutional investors on issues of securities litigation and corporate governance. Over the past 25 years, we have successfully litigated hundreds of securities fraud, antitrust, and consumer fraud class actions, recovering billions of dollars on behalf of defrauded investors and consumers.\nNOTEWORTHY SUCCESSES\nBernstein Liebhard has successfully represented public pension funds, institutional investors and individual investors in hundreds of securities class actions.\n$586 Million\nRecovered for InvestorsInitial Public Offering Litigation\n$400 Million\nRecovered for InvestorsIn re Marsh & McLennan Cos., Inc. Securities Litigation\n$166 Million\nRecovered for InvestorsIn re Royal Dutch/Shell Transport Securities Litigation\n$153 Million\nRecovered for InvestorsIn re Fannie Mae Securities Litigation\n$100 Million\nRecovered for InvestorsIn re Tremont Securities Law, State Law and Insurance Litigation"
    },
    {
      "url": "https://www.globenewswire.com/Tracker?data=BAwvMi83kDLokLKaN84CbwwtMGTkI0X-HWmPEv9xFPcXeYwSfnIorWH3rqn61oWxAgNUM3KyvJFBHsJexn3U_aBiqRbKb_KR6d602YF-6jE=",
      "text": "Bernstein Liebhard LLP is a nationally-recognized securities litigation firm, advising individual and institutional investors on issues of securities litigation and corporate governance. Over the past 25 years, we have successfully litigated hundreds of securities fraud, antitrust, and consumer fraud class actions, recovering billions of dollars on behalf of defrauded investors and consumers.\nNOTEWORTHY SUCCESSES\nBernstein Liebhard has successfully represented public pension funds, institutional investors and individual investors in hundreds of securities class actions.\n$586 Million\nRecovered for InvestorsInitial Public Offering Litigation\n$400 Million\nRecovered for InvestorsIn re Marsh & McLennan Cos., Inc. Securities Litigation\n$166 Million\nRecovered for InvestorsIn re Royal Dutch/Shell Transport Securities Litigation\n$153 Million\nRecovered for InvestorsIn re Fannie Mae Securities Litigation\n$100 Million\nRecovered for InvestorsIn re Tremont Securities Law, State Law and Insurance Litigation"
    }
  ],
  "argos_summary": "Bernstein Liebhard LLP has issued a shareholder alert reminding investors in RxSight Inc. (NASDAQ: RXST) of an upcoming deadline for a securities fraud class action lawsuit filed on behalf of those who purchased shares between November 7, 2024, and July 8, 2025. The lawsuit alleges that RxSight overstated demand for its products and failed to disclose adoption challenges and structural issues that led to declining sales. Investors who wish to join the class or serve as lead plaintiff must file papers by September 22, 2025, while participation requires no fees on a contingency basis.",
  "argos_id": "U3BV41W2A"
}